Peter Attia· MD
let's be clear there were zero additional deaths due to HRT from breast cancer there were more cases one in a thousand women increase in case but it translated to nothing in deaths
Loading…
The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
let's be clear there were zero additional deaths due to HRT from breast cancer there were more cases one in a thousand women increase in case but it translated to nothing in deaths
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
while the Women's Health Initiative demonstrated that women taking conjugated equin estrogen plus MPA had a 25% increase in the risk of breast cancer um it did it never translated to an increase in mortality
and sure enough that guy had confess to me that it did not cause there were no increase in breast cancer deaths you know maybe with a gun to his head when we were you know I was doing the interview with him but yeah not a single increase in breast cancer deaths unbel and that was at the time of publication that was again demonstrated N9 years later and again demonstrated 20 years later on the followup of the same cohort
Even if you believe the results of that study, and you've offered a great explanation for why the actual results should be questioned, but even if you take them at face value, for every 1,000 women who were put on HRT, an additional one got breast cancer, though she didn't die from it, at any increase rate to the women who didn't get the hormone.
For symptomatic perimenopausal women under 60, hormone replacement therapy reduces all-cause mortality.
The breast-cancer risk attributed to HRT in the original WHI trial was overstated and the timing window matters most.